Lv2
200 积分 2024-07-02 加入
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
1天前
已完结
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus
2天前
已完结
DE NOVO COLLAPSING GLOMERULOPATHY IN RENAL ALLOGRAFTS1
1个月前
已关闭
Focal and segmental glomerulosclerosis in renal allograft recipients: A clinico-pathologic study of 37 cases
1个月前
已关闭
Advances in primary glomerulonephritis
1个月前
已完结
Current understanding of the molecular mechanisms of circulating permeability factor in focal segmental glomerulosclerosis
1个月前
已完结
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
1个月前
已完结
De Novo Glomerular Diseases after Renal Transplantation
1个月前
已完结
Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statements
1个月前
已完结
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
1个月前
已完结
皖公网安备34019202002308
